Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in adults aged 50 years or older with prior herpes zoster
2016-000744-34Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in herpes zoster (HZ) comparing Shingrix with Placebo (2 arms). Primary endpoint: Number of confirmed Herpes Zoster cases. Started Jun 2019; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2016-000744-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000744-34.